Cargando…
Development of a Risk Nomogram Model for Identifying Interstitial Lung Disease in Patients With Rheumatoid Arthritis
The clinical features of rheumatoid arthritis (RA)-associated interstitial lung disease (ILD) (RA-ILD) usually manifest to an advanced stage of lung disease, which leads the challenge of early diagnosis and the difficulty in guiding treatments for patients with RA-ILD in clinical settings. The aim o...
Autores principales: | Xue, Jing, Hu, Wenfeng, Wu, Shuang, Wang, Jing, Chi, Shuhong, Liu, Xiaoming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9245420/ https://www.ncbi.nlm.nih.gov/pubmed/35784288 http://dx.doi.org/10.3389/fimmu.2022.823669 |
Ejemplares similares
-
Modeling using clinical examination indicators predicts interstitial lung disease among patients with rheumatoid arthritis
por: Wang, Yao, et al.
Publicado: (2017) -
Serum CHI3L1 as a biomarker of interstitial lung disease in rheumatoid arthritis
por: Yu, Rui, et al.
Publicado: (2023) -
Duration of rheumatoid arthritis and the risk of developing interstitial lung disease
por: Mohning, Michael P., et al.
Publicado: (2021) -
Integrating bioinformatic resources to identify characteristics of rheumatoid arthritis-related usual interstitial pneumonia
por: Qiu, Yulu, et al.
Publicado: (2023) -
Proteome Profiling Identifies Serum Biomarkers in Rheumatoid Arthritis
por: Hu, Congqi, et al.
Publicado: (2022)